182 related articles for article (PubMed ID: 22301904)
1. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease.
Sun N; Liang J; Abil Z; Zhao H
Mol Biosyst; 2012 Apr; 8(4):1255-63. PubMed ID: 22301904
[TBL] [Abstract][Full Text] [Related]
2. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs.
Sun N; Zhao H
Biotechnol Bioeng; 2014 May; 111(5):1048-53. PubMed ID: 23928856
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells.
Hoban MD; Lumaquin D; Kuo CY; Romero Z; Long J; Ho M; Young CS; Mojadidi M; Fitz-Gibbon S; Cooper AR; Lill GR; Urbinati F; Campo-Fernandez B; Bjurstrom CF; Pellegrini M; Hollis RP; Kohn DB
Mol Ther; 2016 Sep; 24(9):1561-9. PubMed ID: 27406980
[TBL] [Abstract][Full Text] [Related]
4. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
5. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
[TBL] [Abstract][Full Text] [Related]
6. Nuclease-mediated gene editing by homologous recombination of the human globin locus.
Voit RA; Hendel A; Pruett-Miller SM; Porteus MH
Nucleic Acids Res; 2014 Jan; 42(2):1365-78. PubMed ID: 24157834
[TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
Cottle RN; Lee CM; Archer D; Bao G
Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
[TBL] [Abstract][Full Text] [Related]
8. Efficient targeted mutagenesis in medaka using custom-designed transcription activator-like effector nucleases.
Ansai S; Sakuma T; Yamamoto T; Ariga H; Uemura N; Takahashi R; Kinoshita M
Genetics; 2013 Mar; 193(3):739-49. PubMed ID: 23288935
[TBL] [Abstract][Full Text] [Related]
9. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.
Holkers M; Cathomen T; Gonçalves MA
Methods; 2014 Sep; 69(2):179-87. PubMed ID: 24561826
[TBL] [Abstract][Full Text] [Related]
11. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
[TBL] [Abstract][Full Text] [Related]
12. Designing and testing the activities of TAL effector nucleases.
Lin Y; Cradick TJ; Bao G
Methods Mol Biol; 2014; 1114():203-19. PubMed ID: 24557905
[TBL] [Abstract][Full Text] [Related]
13. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity.
Mussolino C; Alzubi J; Fine EJ; Morbitzer R; Cradick TJ; Lahaye T; Bao G; Cathomen T
Nucleic Acids Res; 2014 Jun; 42(10):6762-73. PubMed ID: 24792154
[TBL] [Abstract][Full Text] [Related]
14. Targeted mutagenesis of Arabidopsis thaliana using engineered TAL effector nucleases.
Christian M; Qi Y; Zhang Y; Voytas DF
G3 (Bethesda); 2013 Oct; 3(10):1697-705. PubMed ID: 23979944
[TBL] [Abstract][Full Text] [Related]
15. Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
Hu R; Wallace J; Dahlem TJ; Grunwald DJ; O'Connell RM
PLoS One; 2013; 8(5):e63074. PubMed ID: 23667577
[TBL] [Abstract][Full Text] [Related]
16. Efficient disruption of endogenous Bombyx gene by TAL effector nucleases.
Sajwan S; Takasu Y; Tamura T; Uchino K; Sezutsu H; Zurovec M
Insect Biochem Mol Biol; 2013 Jan; 43(1):17-23. PubMed ID: 23142190
[TBL] [Abstract][Full Text] [Related]
17. TAL effector nucleases induce mutations at a pre-selected location in the genome of primary barley transformants.
Wendt T; Holm PB; Starker CG; Christian M; Voytas DF; Brinch-Pedersen H; Holme IB
Plant Mol Biol; 2013 Oct; 83(3):279-85. PubMed ID: 23689819
[TBL] [Abstract][Full Text] [Related]
18. Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs).
Lei Y; Guo X; Liu Y; Cao Y; Deng Y; Chen X; Cheng CH; Dawid IB; Chen Y; Zhao H
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17484-9. PubMed ID: 23045671
[TBL] [Abstract][Full Text] [Related]
19. A library of TAL effector nucleases spanning the human genome.
Kim Y; Kweon J; Kim A; Chon JK; Yoo JY; Kim HJ; Kim S; Lee C; Jeong E; Chung E; Kim D; Lee MS; Go EM; Song HJ; Kim H; Cho N; Bang D; Kim S; Kim JS
Nat Biotechnol; 2013 Mar; 31(3):251-8. PubMed ID: 23417094
[TBL] [Abstract][Full Text] [Related]
20. Nuclease-stimulated homologous recombination at the human β-globin gene.
Vannocci T; Kurata H; de la Fuente J; Roberts IA; Porter AC
J Gene Med; 2014; 16(1-2):1-10. PubMed ID: 24590875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
